Tilray Brands (TLRY) Interest Expenses (2018 - 2019)
Tilray Brands (TLRY) reported Interest Expenses of $41.9 million for Q4 2019, up 305.36% on a YoY basis from $10.3 million in Q4 2018, and up 305.36% quarter-over-quarter from $10.3 million in Q4 2018.
Tilray Brands (TLRY) Interest Expenses (2018 - 2019) Analysis & Trends
Tilray Brands has reported Interest Expenses for 2 years, with the latest figure at $41.9 million in Q4 2019.
- For the quarter ending Q4 2019, Interest Expenses rose 305.36% year-over-year to $41.9 million; the trailing twelve-month figure through Dec 2019 stood at $41.9 million (up 305.36% YoY), and the FY2025 full-year result was $41.3 million, down 16.1% from the prior year.
- Interest Expenses for Q4 2019 stood at $41.9 million, up from $10.3 million in the prior quarter.
- The five-year high for Interest Expenses was $41.9 million in Q4 2019, with the low at $946000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 4.86 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Tilray Brands | - | - | 54.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 41.90 Mn |
| Dec 31, 2019 | 41.90 Mn |
| Dec 31, 2018 | 10.34 Mn |
| Dec 31, 2018 | 10.34 Mn |
| Sep 30, 2018 | 2.85 Mn |
| Sep 30, 2018 | 2.85 Mn |
| Jun 30, 2018 | 946,000.00 |
| Jun 30, 2018 | 946,000.00 |